Theranexus Société Anonyme Toekomstige groei
Future criteriumcontroles 3/6
Theranexus Société Anonyme is forecast to grow earnings at 89.9% per annum.
Belangrijke informatie
-1.6%
Groei van de winst
n/a
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 17.2% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | 27 Sep 2024 |
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 2 | -3 | -5 | -5 | N/A |
| 3/31/2024 | 1 | -5 | -6 | -6 | N/A |
| 12/31/2023 | 0 | -7 | -6 | -6 | N/A |
| 9/30/2023 | 0 | -7 | -6 | -6 | N/A |
| 6/30/2023 | 0 | -7 | -6 | -6 | N/A |
| 3/31/2023 | 0 | -7 | -6 | -6 | N/A |
| 12/31/2022 | 0 | -7 | -5 | -5 | N/A |
| 9/30/2022 | 0 | -7 | -6 | -6 | N/A |
| 6/30/2022 | 0 | -8 | -7 | -7 | N/A |
| 3/31/2022 | 0 | -8 | -6 | -6 | N/A |
| 12/31/2021 | 0 | -8 | -6 | -6 | N/A |
| 9/30/2021 | 0 | -7 | -7 | -7 | N/A |
| 6/30/2021 | 0 | -6 | -8 | -8 | N/A |
| 3/31/2021 | 0 | -5 | -7 | -7 | N/A |
| 12/31/2020 | 0 | -5 | -6 | -6 | N/A |
| 9/30/2020 | 0 | -5 | -4 | -4 | N/A |
| 6/30/2020 | 0 | -6 | -3 | -2 | N/A |
| 3/31/2020 | 0 | -6 | -5 | -3 | N/A |
| 12/31/2019 | 1 | -6 | -7 | -5 | N/A |
| 9/30/2019 | 1 | -6 | -7 | -6 | N/A |
| 6/30/2019 | 1 | -6 | -7 | -6 | N/A |
| 3/31/2019 | 0 | -6 | -7 | -6 | N/A |
| 12/31/2018 | 0 | -5 | -6 | -6 | N/A |
| 9/30/2018 | 0 | -4 | -5 | -5 | N/A |
| 6/30/2018 | 0 | -3 | -4 | -4 | N/A |
| 3/31/2018 | 0 | -3 | N/A | -3 | N/A |
| 12/31/2017 | 0 | -2 | N/A | -2 | N/A |
| 9/30/2017 | 0 | -2 | N/A | -2 | N/A |
| 6/30/2017 | 0 | -2 | N/A | -1 | N/A |
| 3/31/2017 | 0 | -2 | N/A | -1 | N/A |
| 12/31/2016 | 0 | -2 | N/A | -1 | N/A |
| 12/31/2015 | 1 | -1 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: ALTHX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).
Winst versus markt: ALTHX is forecast to become profitable over the next 3 years, which is considered above average market growth.
Hoge groeiwinsten: ALTHX is expected to become profitable in the next 3 years.
Omzet versus markt: Insufficient data to determine if ALTHX's revenue is forecast to grow faster than the French market.
Hoge groei-inkomsten: Insufficient data to determine if ALTHX's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if ALTHX's Return on Equity is forecast to be high in 3 years time